You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Hi there,
I have used BayesPrism to deconvolute my datasets utilizing reference data from a public database. My datasets consist entirely of human bone marrow mesenchymal stem cells and are not cancer samples.
After obtaining the deconvolution results from BayesPrism, I reorganized the data and imported it into a Seurat object. I aimed to generate a UMAP plot resembling the reference scRNA-seq data. However, I observed that the deconvoluted results displayed fewer clusters compared to the reference data.
I am seeking advice on whether it is feasible to achieve the same number of clusters as observed in the reference scRNA-seq data. Additionally, I would appreciate insights on whether aiming for the same cluster count makes sense in this context.
Thank you very much for your assistance.
The text was updated successfully, but these errors were encountered:
Dear user,
Thank you for your question.
When clustering using deconvolved cell type-specific gene expression, it is
typically expected to observe lower variance than the un-deconvolved data,
and hence fewer clusters. This is because the deconvolved cell
type-specific gene expression has removed the variance due to the changes
in the cell type abundance, and focuses on variance in the expression of a
single cell type.
One suggestion for performing downstream analysis using deconvolved cell
type-specific gene expression is to subset on samples of high abundance of
the cell type, as this will yield more confident inference of cell
type-specific gene expression profile. You may refer to Fig 1h in the
BayesPrism paper for the details of such effects.
Best,
Tinyi
On Thu, Jul 25, 2024 at 9:53 AM JaneeeeeeW ***@***.***> wrote:
Hi there,
I have used BayesPrism to deconvolute my datasets utilizing reference data
from a public database. My datasets consist entirely of human bone marrow
mesenchymal stem cells and are not cancer samples.
After obtaining the deconvolution results from BayesPrism, I reorganized
the data and imported it into a Seurat object. I aimed to generate a UMAP
plot resembling the reference scRNA-seq data. However, I observed that the
deconvoluted results displayed fewer clusters compared to the reference
data.
I am seeking advice on whether it is feasible to achieve the same number
of clusters as observed in the reference scRNA-seq data. Additionally, I
would appreciate insights on whether aiming for the same cluster count
makes sense in this context.
Thank you very much for your assistance.
—
Reply to this email directly, view it on GitHub
<#94>, or unsubscribe
<https://github.com/notifications/unsubscribe-auth/AB4NHS66ETZSWZ2IMRSJGDDZOD7O7AVCNFSM6AAAAABLOTRZQOVHI2DSMVQWIX3LMV43ASLTON2WKOZSGQZTAMBTGYZDIMA>
.
You are receiving this because you are subscribed to this thread.Message
ID: ***@***.***>
Hi there,
I have used BayesPrism to deconvolute my datasets utilizing reference data from a public database. My datasets consist entirely of human bone marrow mesenchymal stem cells and are not cancer samples.
After obtaining the deconvolution results from BayesPrism, I reorganized the data and imported it into a Seurat object. I aimed to generate a UMAP plot resembling the reference scRNA-seq data. However, I observed that the deconvoluted results displayed fewer clusters compared to the reference data.
I am seeking advice on whether it is feasible to achieve the same number of clusters as observed in the reference scRNA-seq data. Additionally, I would appreciate insights on whether aiming for the same cluster count makes sense in this context.
Thank you very much for your assistance.
The text was updated successfully, but these errors were encountered: